
- Pharmaceutical Technology-05-15-2018
- Volume 2018 eBook
- Issue 1
Ready-to-Use Parenteral Packaging Components Address Evolving Aseptic Fill/Finish Requirements
Ready-to-use components eliminate the need for component preparation by the drug product manufacturer, enabling them to streamline their processes and focus on their core competencies, such as drug product development and manufacturing.
Drug product and parenteral packaging component manufacturers are continuously evolving in alignment with the advancements in technology and increasing regulatory requirements to better ensure the quality and safety of injectable drug products for patients. The incorporation of barrier technology and flexible fillers and the use of ready-to-use (RTU) packaging components are rapidly gaining adoption as safe and effective solutions for fill/finish processes and container closure systems, respectively.
Article Details
Pharmaceutical Technology
	eBook: Biologics and Sterile Drug Manufacturing  
	Vol. 42
	May 2018
	Pages: 44–46
Citation
When referring to this article, please cite it as S. Cote, “Ready-to-Use Parenteral Packaging Components Address Evolving Aseptic Fill/Finish Requirements,” Pharmaceutical Technology Biologics and Sterile Drug Manufacturing eBook (May 2018).
Articles in this issue
over 7 years ago
Impact of Agitator Design on Bioreactor Performanceover 7 years ago
Characterizing a Bioprocess with Advanced Data Analyticsover 7 years ago
Can Standards Help Pharma Modernize Lyophilization?over 7 years ago
Residual Moisture Testing Methods for Lyophilized Drug Productsover 7 years ago
Albumin Attachment Can Make Better Biobettersover 7 years ago
Lies That Environmental Monitoring Systems Tellover 7 years ago
Understanding Validation and Technical Transferover 7 years ago
New Technologies Streamline Fill/Finish ManufacturingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.




